Inovio Stock Performance

INO
 Stock
  

USD 1.97  0.07  3.43%   

The company retains a Market Volatility (i.e., Beta) of 2.1089, which attests to a somewhat significant risk relative to the market. Let's try to break down what Inovio's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Inovio Pharmaceuticals will likely underperform. Even though it is essential to pay attention to Inovio Pharmaceuticals current price history, it is always good to be careful when utilizing equity current price movements. Our philosophy towards determining any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Inovio Pharmaceuticals exposes twenty-seven different technical indicators, which can help you to evaluate its performance. Inovio Pharmaceuticals has an expected return of -0.0928%. Please be advised to check out Inovio Pharmaceuticals maximum drawdown, as well as the relationship between the expected short fall and rate of daily change to decide if Inovio Pharmaceuticals performance from the past will be repeated at some point in the near future.
  
Inovio Performance
0 of 100
Over the last 90 days Inovio Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Inovio Pharmaceuticals is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors. ...more

Structure and Payout Changes

Last Split Factor
1:4
Last Split Date
2014-06-06

Inovio Price Channel

Begin Period Cash Flow250728118.00
Total Cashflows From Investing Activities-175344484.00

Inovio Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  220.00  in Inovio Pharmaceuticals on September 2, 2022 and sell it today you would lose (29.50)  from holding Inovio Pharmaceuticals or give up 13.41% of portfolio value over 90 days. Inovio Pharmaceuticals is generating negative expected returns assuming volatility of 5.2719% on return distribution over 90 days investment horizon. In other words, 45% of stocks are less volatile than Inovio, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Daily Expected Return (%)  
       Risk (%)  
Considering the 90-day investment horizon Inovio Pharmaceuticals is expected to under-perform the market. In addition to that, the company is 3.5 times more volatile than its market benchmark. It trades about -0.02 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.08 per unit of volatility.

Inovio Pharmaceuticals Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Inovio Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Inovio Pharmaceuticals, and traders can use it to determine the average amount a Inovio Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0176

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsINO
Estimated Market Risk
 5.27
  actual daily
 
 45 %
of total potential
 
4545
Expected Return
 -0.09
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 -0.02
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average Inovio Pharmaceuticals is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Inovio Pharmaceuticals by adding it to a well-diversified portfolio.

About Inovio Pharmaceuticals Performance

To evaluate Inovio Pharmaceuticals Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Inovio Pharmaceuticals generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Inovio Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Inovio Pharmaceuticals market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Inovio's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Effect of Exchange Rate Changes on Cash-30.1 K-30.9 K
Return on Investment(67.35) (72.67) 
Return on Average Assets(58.64) (63.27) 
Return on Average Equity(70.55) (76.12) 
Return on Invested Capital(0.65) (0.70) 
Return on Sales(170.01) (174.48) 

Things to note about Inovio Pharmaceuticals

Checking the ongoing alerts about Inovio Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Inovio Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Inovio Pharmaceuticals Alerts

Equity Alerts and Improvement Suggestions

Inovio Pharmaceuticals generated a negative expected return over the last 90 days
Inovio Pharmaceuticals has high historical volatility and very poor performance
Inovio Pharmaceuticals may become a speculative penny stock
The company reported the last year's revenue of 1.77 M. Reported Net Loss for the year was (303.66 M) with loss before taxes, overhead, and interest of (247.47 M).
Inovio Pharmaceuticals has about 348.13 M in cash with (215.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.4.
Inovio Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: INOVIO Provides an Update on Lassa Fever and MERS Programs - Marketscreener.com
Please see Risk vs Return Analysis. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for analysis

When running Inovio Pharmaceuticals price analysis, check to measure Inovio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inovio Pharmaceuticals is operating at the current time. Most of Inovio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Inovio Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inovio Pharmaceuticals' price. Additionally, you may evaluate how the addition of Inovio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Is Inovio Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
509 M
Quarterly Revenue Growth YOY
30.38
Return On Assets
(0.43) 
Return On Equity
(0.92) 
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Inovio Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.